TRAM-34 inhibits nonselective cation channels
TRAM-34 has been demonstrated to inhibit intermediate-conductance Ca2+-activated K+ channels in a wide variety of cell types, including immune cells. In the present study, we investigated effects of TRAM-34 on microglial cells stimulated with lysophosphatidylcholine (LPC). LPC-induced increases in the intracellular Ca2+ concentration of microglial cells were effectively reduced in the presence of TRAM-34. At a concentration of 1 μM, TRAM-34 inhibited LPC-induced Ca2+ signals by 60%. The TRAM-34-induced reduction of LPC-induced Ca2+ increases cannot be related to the inhibition of Ca2+-activated K+ channels. In contrast to TRAM-34, the Ca2+-activated K+ channel inhibitor charybdotoxin did not affect LPC-induced increases in the intracellular Ca2+ concentration of microglial cells. Patch clamp experiments revealed a direct inhibitory effect of TRAM-34 on nonselective cation channels. Half-maximal inhibition of LPC-induced nonselective cation currents was determined at 38 nM TRAM-34. These data indicate that TRAM-34 may cause additional effects on immune cells that are unrelated to the well-described inhibition of Ca2+-activated K+ channels.
KeywordsBrain macrophages Nonselective cation current TRAM-34 Charybdotoxin Immune cells TRP channels
This work was supported by the Deutsche Forschungsgemeinschaft grant SFB 507/C7. The authors wish to thank Itohan Akhionbare for technical assistance.
- 1.Beeton C, Wulff H, Barbaria J, Clot-Faybesse O, Pennington M, Bernard D, Cahalan MD, Chandy KG, Beraud E (2001) Selective blockade of T lymphocyte K+ channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc Natl Acad Sci USA 98:13942–13947PubMedCrossRefGoogle Scholar
- 7.Reich EP, Cui L, Yang L, Pugliese-Sivo C, Golovko A, Petro M, Vassileva G, Chu I, Nomeir AA, Zhang LK, Liang X, Kozlowski JA, Narula SK, Zavodny PJ, Chou CC (2005) Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice. Eur J Immunol 35:1027–1036PubMedCrossRefGoogle Scholar